Hiroshi Nakagomi - Concepedia

Author

Hiroshi Nakagomi

Yamanashi Prefectural Central Hospital ORCID

Also Known As

H Nakagomi, H. Nakagomi, Hiroshi NAKAGOMI, Hiroshi Nakagomi, Hiroshi Nakagomi*, Nagy, M. I., Nakagawa, I.

111

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Yamanashi Prefectural Central Hospital The University of Tokyo University of Yamanashi Karolinska Institutet Karolinska University Hospital

About

Hiroshi Nakagomi is an author at Yamanashi Prefectural Central Hospital specializing in medicine, breast cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	904
2	Cell Biology	4	4	211
3	Public Health	2	2	96
4	Health Sciences	1	1	96
5	Family Medicine	1	1	15

Hiroshi Nakagomi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Hiroshi Nakagomi, Max Petersson, I Magnusson, PubMed ImmunologyImmune RegulationPathologySignal-transducing Zeta ChainsNk Cells	1993	344
The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma lines Hiroshi Nakagomi, Riccardo Dolcetti, Maria Teresa Bejarano, International Journal of Cancer Burkitt Lymphoma LinesImmunologyPathologyImmunologic MechanismImmune System	1994	140
Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma Hiroshi Nakagomi, Pavel Pisa, Eva K. Pisa, International Journal of Cancer	1995	128
Increased Nuclear Localization of Transcription Factor Y-Box Binding Protein 1 Accompanied by Up-Regulation of P-glycoprotein in Breast Cancer Pretreated with Paclitaxel Tomoyuki Fujita, Ken‐ichi Ito, Hiroto Izumi, Clinical Cancer Research	2005	97
Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer Masayuki Inoue, Hiroshi Nakagomi, Haruka Nakada, Breast Cancer Specific SitesSurgical OncologyMetastatic Breast CancerBreast OncologyInvasive Lobular Carcinoma	2017	96
Multigene panel analysis identified germline mutations of <scp>DNA</scp> repair genes in breast and ovarian cancer Yosuke Hirotsu, Hiroshi Nakagomi, Ikuko Sakamoto, Molecular Genetics & Genomic Medicine Genome InstabilityBreast OncologySomatic VariantCancer RiskMedicine	2015	81
Detection of <i>BRCA1</i> and <i>BRCA2</i> germline mutations in Japanese population using next‐generation sequencing Yosuke Hirotsu, Hiroshi Nakagomi, Ikuko Sakamoto, Molecular Genetics & Genomic Medicine	2014	62
<scp><i>BRCA</i></scp><i>1</i> and <scp><i>BRCA</i></scp><i>2</i> mutations in <scp>J</scp>apanese patients with ovarian, fallopian tube, and primary peritoneal cancer Ikuko Sakamoto, Yosuke Hirotsu, Hiroshi Nakagomi, Cancer	2015	56
Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient Yosuke Hirotsu, Hiroshi Nakagomi, Kenji Amemiya, Medical Oncology Breast Cancer PatientBreast OncologyMedicineBreast CancerCancer Genetics	2016	42
Touch imprint cytology with massively parallel sequencing (TIC‐seq): a simple and rapid method to snapshot genetic alterations in tumors Kenji Amemiya, Yosuke Hirotsu, Taichiro Goto, Cancer Medicine	2016	41

Page 1